
Keywords: مولیبدن کافاکور; α-AASA; α-amino adipic semialdehyde; cPMP; cyclic pyranopterin monophosphate; HIE; hypoxic ischemic encephalopathy; Moco; molybdenum cofactor; MoCD; molybdenum cofactor deficiency; Molybdenum cofactor deficiency; Cyclic PMP; Neonatal seizures; S-sulfocy